ATPAF2 Inhibitors

ATPAF2 consits of inhibitors like Oligomycin A, Antimycin A, Rotenone, TTFA, Carboxin, Azide, and Cyanide operate by directly binding to and inhibiting key enzymes within the ETC. These inhibitors lead to a reduction in electron flow, which subsequently lowers the proton gradient across the mitochondrial inner membrane. The decrease in proton motive force directly impacts ATP synthase, the enzyme complex responsible for harnessing the energy of the proton gradient to synthesize ATP. Inhibition of ATP synthase by these chemicals can result in an environment where ATPAF2's role in the assembly of ATP synthase is less critical, as the driving force for ATP production is compromised.

Additional compounds, such as Bongkrekic acid and Atractyloside, target the adenine nucleotide translocator, a protein that facilitates the exchange of ATP and ADP between the mitochondrial matrix and the cytosol. By impeding the ANT, these inhibitors interrupt the supply of ADP to the mitochondrial matrix, which is necessary for continuous ATP synthesis by ATP synthase. The uncouplers, 2,4-Dinitrophenol and FCCP, function by dissipating the proton gradient without affecting electron transport, effectively decoupling the ETC from ATP synthesis. This action collapses the electrochemical gradient, rendering ATP synthase incapable of producing ATP. Aurovertin B directly inhibits ATP synthase by binding to its β-subunit, preventing both ATP synthesis and hydrolysis.